October 25, 2002
Multivitamin supplements may help some HIV-positive pregnant women reduce the risk of transmitting the virus to their children and improve certain aspects of their babies' health, according to US and African researchers. However, Dr. Wafaie Fawzi of Harvard School of Public Health and colleagues also found that supplements of vitamin A alone actually increased mother-to-child HIV transmission during pregnancy or while breast-feeding. Their report, "Randomized Trial of Vitamin Supplements in Relation to Transmission of HIV-1 Through Breastfeeding and Early Child Mortality," was published in AIDS (2002;16:1935-1944).
As to why vitamin A supplements may increase the risk of children acquiring the virus from their mothers, Fawzi noted that past studies have shown the same result. Previous research found that vitamin A may increase the replication of HIV in infected cells, while another study reported that people with low levels of vitamin A in their blood were less likely than others to transmit the virus via heterosexual sex.
Half of the 1,078 pregnant HIV-positive women in the study received vitamin A supplements, while the others were given multivitamins without vitamin A. The researchers followed the women and their children from when they were 20 weeks along in the pregnancy through breast-feeding. Women who took vitamin A supplements were 38 percent more likely to transmit HIV to their children than women who received multivitamins. Multivitamins appeared to offer no benefit in preventing mother-to-child HIV transmission, except in women with low levels of white blood cells -- an indication of advanced disease -- who were 60 percent less likely to infect their children while breast feeding than women with low levels of the cells who were not given multivitamins.
In an interview, Fawzi said that providing pregnant HIV- positive women with multivitamins throughout their pregnancy could potentially be a cost-effective means of keeping their children healthy. "Prices of vitamins would be driven to a low level if mass production is undertaken for all women at risk," Fawzi said.
Adapted from:
Reuters Health
10.10.02; Alison McCook
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|